Waters-Becton-Dickinson deal receives antitrust clearance in the US
Waters Corp.’s deal to merge with Becton, Dickinson and Co.’s Biosciences & Diagnostic Solutions business for $17.5 billion has received antitrust clearance in the United States.Waters Corp.’s deal to merge with...To view the full article, register now.
Already a subscriber? Click here to view full article